# BioPharma Credit PLC USD (BPCP)

**Page:** https://fundology.uk/fund/bpcp · ISIN GB00BDGKMY29

## At a glance

> Capital at risk. Past performance is not a guide to future returns. The value of investments can fall as well as rise.

As of 13/11/2026, BPCP (BioPharma Credit PLC USD, ISIN GB00BDGKMY29) closed at £0.754 on the London Stock Exchange. Over the five years to 13/11/2026 its price changed by +5.8% (income paid out is not included), or −17.5% after UK CPIH inflation.

## Summary

BioPharma Credit PLC USD is an investment trust. You buy and sell it through a share-dealing account or platform during stock-market hours, like a share.

Latest close: **£0.754** (13/11/2026).

## Key facts

| Fact | Value |
|---|---|
| Ticker (LSE) | BPCP |
| ISIN | GB00BDGKMY29 |
| Also listed as | BPCR (London Stock Exchange, US dollars) |
| Category | Corporate & other bonds |
| Type | Investment trust |
| Domicile | United Kingdom |

## Past returns (periods to 13/11/2026)

After the fund's ongoing charges. "Income reinvested" is total return; "price only" leaves out income paid out. Real returns are after UK CPIH inflation.

| Window | Return | After CPIH inflation | Measured as |
|---|---|---|---|
| 1 year | +9.59% | +5.71% | price only |
| 3 years | +11.70% | +0.92% | price only |
| 5 years | +5.75% | -17.46% | price only |

Returns: worked out from recorded daily closes. Inflation: UK CPIH, latest month published.

## Calendar-year returns

Calendar-year returns of BioPharma Credit PLC USD in pounds (price only, income paid out not included): 2022 +6.6%, 2023 −14.6%, 2024 +3.8%, 2025 −0.9%; 2026 to 13/11/2026 +10.6%. Returns of BioPharma Credit PLC USD in pounds (price only, income paid out not included) over the 12 months to 30/09/2026: +9.7%; to 30/09/2025: −0.6%; to 30/09/2024: −1.6%; to 30/09/2023: −18.0%.

| Year | Return | After CPIH inflation | Measured as |
|---|---|---|---|
| 2022 | +6.6% | -2.4% | Price |
| 2023 | -14.6% | -18.0% | Price |
| 2024 | +3.8% | +0.2% | Price |
| 2025 | -0.9% | -4.3% | Price |
| 2026 to 13/11/2026 | +10.6% | +7.0% | Price |

## Risk metrics

| Window | Volatility | Max drawdown |
|---|---|---|
| 1 year | 9.88% | -4.85% |
| 3 years | 11.24% | -13.42% |
| 5 years | 11.34% | -25.78% |

## Largest fall

Volatility of BioPharma Credit PLC USD in pounds, annualised from weekly returns to 13/11/2026: 9.9% over 1 year, 11.2% over 3 years, 11.3% over 5 years. Largest fall in the price of BioPharma Credit PLC USD since November 2021, in pounds: −25.8% from 23/09/2022 to 11/04/2025. The lowest 12-month return of BioPharma Credit PLC USD in pounds (price only, income paid out not included) since October 2021 was −22.8% (12 months to 22/09/2023); the highest was +19.7% (12 months to 04/11/2022). On 13/11/2026 the price of BioPharma Credit PLC USD was 13.2% below its highest weekly close since November 2021 (23/09/2022), in pounds.

## Charges & eligibility

- Stocks and shares ISA eligible: usually (check with your platform)
- SIPP eligible: usually (check with your provider)
- ISA and SIPP mean the kind of product usually qualifies under HMRC rules. We do not check each platform’s list — each provider decides which funds it offers. Crypto ETNs have not qualified for a stocks and shares ISA since 06/04/2026, and overseas funds that are not UK-recognised UCITS, such as Swiss ETFs, do not usually qualify.

## Questions people ask

**What is the ISIN of BPCP?**

The ISIN of BPCP is GB00BDGKMY29. An ISIN identifies one exact share class of a fund; BPCP is its ticker on the London Stock Exchange. The same share class is also listed as BPCR (London Stock Exchange, US dollars).

**What were BPCP’s returns in each of the last five years?**

Calendar-year returns of BPCP in pounds (price only, income paid out not included): 2022 +6.6%, 2023 −14.6%, 2024 +3.8%, 2025 −0.9%; 2026 to 13/11/2026 +10.6%. Past performance is not a guide to future returns.

**How has BPCP done after inflation?**

Over the five years to 13/11/2026 BPCP’s price changed by +5.8% (income paid out is not included), or −17.5% after UK CPIH inflation. Past performance is not a guide to future returns.

---

We show information. We are not financial advisers, not authorised by the FCA, and never recommend specific investments.

Capital at risk. Past performance is not a guide to future returns. The value of investments can fall as well as rise.